A Stage 4 lung cancer diagnosis nearly sidelined 33-year-old teacher and athlete, Adrian C. Thanks to precision therapies and supportive care, he reclaimed his active lifestyle—proving that advanced treatments can turn “bonus time” into a hopeful, fulfilling future.
A Remarkable Return to Teaching and Sports After Stage IV Lung Cancer Read More »
A Stage IV non-small cell lung cancer diagnosis at age 42 surprised Anne P., a never-smoker and mother of two. Thanks to comprehensive genomic tumor testing, she now uses targeted therapy for her EGFR- and T790M-positive lung tumors, maintaining an active life and raising awareness about lung cancer research.
“Incurable” Advanced NSCLC to Active Lifestyle Read More »
Genomic testing unlocked a miracle for this survivor, transforming Amy Grove’s difficult Stage IV diagnosis into a stable and hopeful future.
Life-Saving Biomarker Test – MET Amplification “Miracle” Read More »
In 2022, Natasha was diagnosed with stage 4 lung cancer in her late 40s—an unexpected twist for a healthy, active mother and teacher. Discover how an EGFR mutation and targeted therapy offered her renewed hope.
Unmasking EGFR: How Targeted Therapy Gave Natasha a Second Chance Read More »
Targeted therapy and world-class care at Mass General Cancer Center has given Ann M. new lease on life and a passion for inspiring others. Read more about her journey with ROS1-positive lung cancer.
From Shock to Survival—The Role of Targeted Therapy in Her Remarkable Recovery Read More »
When a chance CAT scan revealed stage IV non-small cell lung cancer that had already spread to his adrenal gland, Bob C. faced daunting odds. Yet an innovative immunotherapy trial brought new hope, minimal side effects, and precious extra years of life.
A Clinical Trial and Unyielding Spirit Turned a Dire Diagnosis into an Ongoing Triumph Read More »
In the months leading up to her lung cancer diagnosis, Brandi Bryant had a persistent cough she barely noticed. Wildfire smoke and shortness of breath hinted at deeper issues. Yet she never imagined this nagging cough would turn out to be ALK+ lung cancer. Her eventual diagnosis, intense treatment, and triumphant return to health underscore a powerful journey of resilience and hope.
NED Achieved: A Powerful Fight Against ALK+ Lung Cancer Read More »
Stage IV lung cancer, brain metastases, PD-L1 positive. Treated with chemotherapy and immunotherapy
Complete Brain and Body Response – Immunotherapy Triumph Read More »
Stage IV lung cancer, brain metastasis, ALK-positive. Treated with immunotherapy, chemotherapy, stereotactic radiosurgery, and alectinib
Remarkable outcomes in Advanced ALK-Postive lung cancer Read More »
